Carlsson SV, Vickers AJ. Screening for prostate cancer. Med Clin North Am. 2020;104(6):1051–62.

Article  PubMed  PubMed Central  Google Scholar 

Society AC. Facts & Figures 2022. Atlanta: American Cancer Society. https://www.cancer.org/cancer/prostate-cancer/about/key-statistics.html.

Schroder FH, Hugosson J, Roobol MJ, Tammela TL, Zappa M, Nelen V, et al. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up. Lancet. 2014;384(9959):2027–35.

Article  PubMed  PubMed Central  Google Scholar 

Rosario E, Rosario DJ. (2020) Localized Prostate Cancer.

Hamdy FC, Donovan JL, Lane J, Mason M, Metcalfe C, Holding P, et al. 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. N Engl J Med. 2016;375:1415–24.

Article  PubMed  Google Scholar 

Napoli A, Alfieri G, Scipione R, Leonardi A, Fierro D, Panebianco V, et al. High-intensity focused ultrasound for prostate cancer. Expert Rev Med Devices. 2020;17(5):427–33.

Article  CAS  PubMed  Google Scholar 

Calio B, Kasson M, Sugano D, Ortman M, Gaitonde K, Verma S, et al. Multiparametric MRI: an opportunity for focal therapy of prostate cancer. Semin Roentgenol. 2018;53(3):227–33.

Article  PubMed  Google Scholar 

Marshall S, Taneja S. Focal therapy for prostate cancer: the current status. Prostate Int. 2015;3(2):35–41.

Article  PubMed  PubMed Central  Google Scholar 

Werntz RP, Eggener SE. Novel focal therapy treatment options for prostate cancer. Curr Opin Urol. 2018;28(2):178–83.

Article  PubMed  Google Scholar 

•• Hayes M, Lin-Brande M, Isharwal S. Primary Focal Therapy for Localized Prostate Cancer: A Review of the Literature. Oncology (Williston Park). 2021;35(5):261–8. This paper addresses a critical need in prostate cancer treatment by reviewing various focal therapy approaches and their outcomes. By summarizing the current state of the literature and discussing the advantages and drawbacks of different therapeutic modalities, this paper provides valuable insights for clinicians and researchers. It emphasizes the excellent short- and intermediate-term functional and quality-of-life outcomes associated with focal therapies, highlighting the potential to improve patients' overall well-being.

Blank F, Meyer M, Wang H, Abbas H, Tayebi S, Hsu W-W, et al. Salvage radical prostatectomy after primary focal ablative therapy: a systematic review and meta-analysis. Cancers. 2023;15(10):2727.

Article  PubMed  PubMed Central  Google Scholar 

Kasson M, Ortman M, Gaitonde K, Verma S, Sidana A, editors. Imaging prostate cancer using multiparametric magnetic resonance imaging: past, present, and future. Seminars in Roentgenology; 2018: Elsevier.

• Ahdoot M, Lebastchi AH, Turkbey B, Wood B, Pinto PA. Contemporary treatments in prostate cancer focal therapy. Curr Opin Oncol. 2019;31(3):200–6. This paper provides a comprehensive analysis of the contemporary treatments within this field. By critically examining the latest therapeutic modalities, including advancements in imaging, targeted ablation techniques, and patient selection criteria, the paper offers a nuanced understanding of the evolving landscape of prostate cancer care. Its insights are invaluable for clinicians and researchers, as they navigate the dynamic arena of prostate cancer focal therapy, ultimately aiming to optimize treatment outcomes and enhance the quality of life for patients affected by this prevalent malignancy.

Ahmed HU, Hindley RG, Dickinson L, Freeman A, Kirkham AP, Sahu M, et al. Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study. Lancet Oncol. 2012;13(6):622–32.

Article  PubMed  PubMed Central  Google Scholar 

Bui TL, Glavis-Bloom J, Chahine C, Mehta R, Wolfe T, Bhatter P, et al. Prostate minimally invasive procedures: complications and normal vs. abnormal findings on multiparametric magnetic resonance imaging (mpMRI). Abdom Radiol. 2021;46(9):4388–400.

Article  Google Scholar 

Stabile A, Orczyk C, Hosking-Jervis F, Giganti F, Arya M, Hindley RG, et al. Medium-term oncological outcomes in a large cohort of men treated with either focal or hemi-ablation using high-intensity focused ultrasonography for primary localized prostate cancer. BJU Int. 2019;124(3):431–40.

Article  PubMed  Google Scholar 

Crouzet S, Chapelon JY, Rouviere O, Mege-Lechevallier F, Colombel M, Tonoli-Catez H, et al. Whole-gland ablation of localized prostate cancer with high-intensity focused ultrasound: oncologic outcomes and morbidity in 1002 patients. Eur Urol. 2014;65(5):907–14.

Article  PubMed  Google Scholar 

Bakavicius A, Marra G, Macek P, Robertson C, Abreu AL, George AK, et al. Available evidence on HIFU for focal treatment of prostate cancer: a systematic review. Int Braz J Urol. 2022;48:263–74.

Article  PubMed  Google Scholar 

Huber PM, Afzal N, Arya M, Boxler S, Dudderidge T, Emberton M, et al. Focal HIFU therapy for anterior compared to posterior prostate cancer lesions. World J Urol. 2021;39(4):1115–9.

Article  PubMed  Google Scholar 

Hirst AM, Frame FM, Maitland NJ, O’Connell D. Low temperature plasma: a novel focal therapy for localized prostate cancer? Biomed Res Int. 2014;2014: 878319.

Article  PubMed  PubMed Central  Google Scholar 

Elterman D, Li W, Hatiboglu G, Relle J, Zorn KC, Bhojani N, et al. Relief of lower urinary tract symptoms after MRI-guided transurethral ultrasound ablation for localized prostate cancer: subgroup analyses in patients with concurrent cancer and benign prostatic hyperplasia. J Endourol. 2021;35(4):497–505.

Article  PubMed  Google Scholar 

Klotz L, Pavlovich CP, Chin J, Hatiboglu G, Koch M, Penson D, et al. Magnetic resonance imaging-guided transurethral ultrasound ablation of prostate cancer. J Urol. 2021;205(3):769–79.

Article  PubMed  Google Scholar 

Bomers J, Wright C, Fütterer J. Personalized Treatment for Patients with Prostate Cancer Using MRI-guided Transurethral Ultrasound Ablation (TULSA).

Sundaram KM, Chang SS, Penson DF, Arora S, editors. Therapeutic ultrasound and prostate cancer. Seminars in interventional radiology; 2017: Thieme Medical Publishers.

Righetto* M, Daniele M, Filiberto Z, Mancini M. PD17–05 Lack of accuracy of selection criteria in low-risk prostate cancer patients eligible for focal treaTMENT. The Journal of Urology. 2020;203(Supplement 4):e370-e1.

Shinohara K. Prostate cancer: cryotherapy. Urol Clin North Am. 2003;30(4):725–36.

Article  PubMed  Google Scholar 

Shah TT, Ahmed H, Kanthabalan A, Lau B, Ghei M, Maraj B, et al. Focal cryotherapy of localized prostate cancer: a systematic review of the literature. Expert Rev Anticancer Ther. 2014;14(11):1337–47.

Article  CAS  PubMed  Google Scholar 

• Perera M, Krishnananthan N, Lindner U, Lawrentschuk N. An update on focal therapy for prostate cancer. Nat Rev Urol. 2016;13(11):641–53. holds significant importance in the field of prostate cancer treatment. The paper emphasizes the crucial aspect of patient selection for focal therapy, considering factors like tumor multifocality and the presence of low-grade secondary tumors. It highlights the importance of comprehensive preoperative assessment, including prostate mapping, to ensure the exclusion of high-grade disease before initiating focal therapy. Furthermore, the paper provides an overview of various focal therapy modalities. This paper plays a vital role in guiding clinicians and researchers in the evolving field of focal therapy for prostate cancer, offering insights into patient selection, treatment modalities, and functional outcomes.

Overduin CG, Bomers JG, Jenniskens SF, Hoes MF, Ten Haken B, de Lange F, et al. T1-weighted MR image contrast around a cryoablation iceball: a phantom study and initial comparison with in vivo findings. Med Phys. 2014;41(11): 112301.

Article  PubMed  Google Scholar 

Tacke J, Speetzen R, Heschel I, Hunter DW, Rau G, Gunther RW. Imaging of interstitial cryotherapy–an in vitro comparison of ultrasound, computed tomography, and magnetic resonance imaging. Cryobiology. 1999;38(3):250–9.

Article  CAS  PubMed  Google Scholar 

Ward JF, Jones JS. Focal cryotherapy for localized prostate cancer: a report from the national Cryo On-Line Database (COLD) Registry. BJU Int. 2012;109(11):1648–54.

Article  PubMed  Google Scholar 

Chuang R, Kinnaird A, Kwan L, Sisk A, Barsa D, Felker E, et al. Hemigland cryoablation of clinically significant prostate cancer: intermediate-term followup via magnetic resonance imaging guided biopsy. J Urol. 2020;204(5):941–9.

Article  PubMed  Google Scholar 

Jethwa PR, Barrese JC, Gowda A, Shetty A, Danish SF. Magnetic resonance thermometry-guided laser-induced thermal therapy for intracranial neoplasms: initial experience. Oper Neurosurg. 2012;71(suppl_1):ons133–45.

Article  Google Scholar 

Valerio M, Cerantola Y, Eggener SE, Lepor H, Polascik TJ, Villers A, et al. New and established technology in focal ablation of the prostate: a systematic review. Eur Urol. 2017;71(1):17–34.

Article  PubMed  Google Scholar 

McClure TD, Margolis DJ, Hu JC. Partial gland ablation in the management of prostate cancer: a review. Curr Opin Urol. 2017;27(2):156–60.

Article  PubMed  Google Scholar 

Coleman JA, Scardino PT. Targeted prostate cancer ablation: energy options. Curr Opin Urol. 2013;23(2):123–8.

Article  PubMed  Google Scholar 

Mathew MS, Oto A. MR imaging-guided focal therapies of prostate cancer. Magn Reson Imaging Clin N Am. 2019;27(1):131–8.

Article  PubMed  Google Scholar 

Walser E, Nance A, Ynalvez L, Yong S, Aoughsten JS, Eyzaguirre EJ, et al. Focal laser ablation of prostate cancer: results in 120 patients with low-to intermediate-risk disease. J Vasc Interv Radiol. 2019;30(3):401–9.

Article  PubMed  PubMed Central  Google Scholar 

Feller J, Greenwood B, Jones W, Toth R. Mp30-02 transrectally delivered, outpatient MRI-guided laser focal therapy of prostate cancer: seven year interim results of NCT# 02243033. J Urol. 2018;199(4S):e374–5.

Article  Google Scholar 

Al-Hakeem Y, Raz O, Gacs Z, Maclean F, Varol C. Magnetic resonance image-guided focal laser ablation in clinically localized prostate cancer: safety and efficacy. ANZ J Surg. 2019;89(12):1610–4.

Article  PubMed  Google Scholar 

Van Luijtelaar A, Greenwood BM, Ahmed HU, Barqawi AB, Barret E, Bomers JG, et al. Focal laser ablation as clinical treatment of prostate cancer: report from a Delphi consensus project. World J Urol. 2019;37:2147–53.

Article  PubMed  PubMed Central  Google Scholar 

Bozzini G, Colin P, Nevoux P, Villers A, Mordon S, Betrouni N. Focal therapy of prostate cancer: energies and procedures. Urol Oncol. 2013;31(2):155–67.

Article  CAS  PubMed  Google Scholar 

Azzouzi A-R, Emberton M. Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer–Authors’ reply. Lancet Oncol. 2017;18(4): e188.

Article  PubMed  Google Scholar 

Kasivisvanathan V, Emberton M, Ahmed HU. Focal therapy for prostate cancer: rationale and treatment opportunities. Clin Oncol (R Coll Radiol). 2013;25(8):461–73.

Article  CAS  PubMed  Google Scholar 

Blazevski A, Scheltema MJ, Yuen B, Masand N, Nguyen TV, Delprado W, et al. Oncological and quality-of-life outcomes following focal irreversible electroporation as primary treatment for localised prostate cancer: a biopsy-monitored prospective cohort. Eur Urol Oncol. 2020;3(3):283–90.

Article  PubMed